Eli Lilly And reported $1.69B in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbott ABT:US $ 2.79B 7M
Abbvie ABBV:US $ 3.07B 228M
ALKERMES ALKS:US 139.19M 14.02M
Amgen AMGN:US $ 1.38B 130M
AstraZeneca AZN:LN 2.57B 76M
Astrazeneca AZN:US 2.57B 76M
Baxter International BAX:US $ 648M 44M
Biogen BIIB:US $ 637.3M 42.3M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Catalent CTLT:US $ 184.1M 11.4M
Coherus Biosciences CHRS:US $ 40.34M 954K
Drreddys Laboratories RDY:US 13.75B 816M
Eli Lilly And LLY:US $ 1.69B 109.7M
Endo International Ordinary Shares ENDP:US 170.93M 12.7M
Gilead Sciences GILD:US $ 1.34B 297M
Glaxosmithkline GSK:US 2.5B 183M
GlaxoSmithKline GSK:LN 2.5B 183M
Horizon Pharma HZNP:US 355.2M 23.21M
Intercept Pharmaceuticals ICPT:US $ 57.65M 1.62M
JAZZ PHA JAZZ:US 429.03M 168.52M
Johnson & Johnson JNJ:US $ 6.07B 641M
Lannett LCI:US $ 21.58M 3.94M
Medtronic MDT:US 2.55B 199M
Merk MRK:US $ 2.25B 376M
Neurocrine Biosciences NBIX:US $ 143.2M 14.2M
Novartis NOVN:VX 3.71B 190M
Novartis NVS:US 3.71B 190M
Perrigo Ordinary Shares PRGO:US 271.9M 3M
Pfizer PFE:US $ 2.79B 134M
Phibro Animal Health PAHC:US $ 50.67M 1.64M
Prestige Brands PBH:US $ 61.91M 1.67M
Regeneron Pharmaceuticals REGN:US $ 414.7M 9.1M
Revance Therapeutics RVNC:US $ 49.01M 937K
Teva Pharmaceutical Industries TEVA:US 832M 16M
United Therapeutics UTHR:US $ 112.8M 2.9M
Zoetis ZTS:US $ 495M 86M